Live tape
Top 8, mentions 7d6,216META1,812 mentions▲ +0.06GOOGL1,252 mentions▲ +0.02NVDA718 mentions▲ +0.09MSFT537 mentions▲ +0.06MUSE508 mentions▲ +0.06TSLA480 mentions▲ +0.05SPY475 mentions▲ +0.04QQQ434 mentions▲ +0.07

Equity · Healthcare

CTEV

Claritev Corporation · NYSE

$36 −2.20% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 11, 2026
Price · Chart
Our own end-of-day closes 42 sessions
$50 $20 1 Jul 11 Sep

The line runs $32.41 on 1 July through $36 on 11 September, on a scale from $20 to $50. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CTEV over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 42 sessions over that window: $32.41 on 1 July 2026 through $36 on 11 September 2026.

Market cap $610.1M
52-week range $13 – $72.39
Avg volume 8.7K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 11, 2026

CTEV insider trades

SEC Form 4 · last 90 days · newest reported trade 21 Sep 2026
Open-market buys 2
Open-market sells 3
Net sold $670K
Non-trade filings 3
Date Insider Type Shares Value
21 Sep 2026 Garis Douglas Michael EVP&CFO Sell 9,025 $276K
28 Aug 2026 Dalton Travis Pres., CEO & Executive Chair Buy 1,950 $75K
27 Aug 2026 Dalton Travis Pres., CEO & Executive Chair Buy 4,500 $175K
14 Aug 2026 Misencik Tiffani SVP, Chief Growth Officer Sell 8,850 $355K
10 Aug 2026 Mintz William B. SVP, Chief Strategy Officer Sell 8,431 $289K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Sep 2026 Letham Thomas Benjamin Director Award 2,880
05 Aug 2026 Garis Douglas Michael EVP&CFO Tax withheld 11,711 $306K
05 Aug 2026 Mintz William B. SVP, Chief Strategy Officer Tax withheld 3,622 $95K

CTEV reported financials

SEC EDGAR XBRL

CTEV reported revenue of $965.4M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$284.3M.

Figure Reported Period
Revenue $965.4M 31 Dec 2025 fiscal year
Net income −$284.3M 31 Dec 2025 fiscal year
Diluted EPS −$17.30 31 Dec 2025 fiscal year
Total assets $4.8B 30 Jun 2026 at period end
Total equity −$294.6M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CTEV earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-3.49 $257M
31 Mar 2026 Q1 2026 $-4.41 $245M
31 Dec 2025 FY 2025 $-17.30 $965M
30 Sep 2025 Q3 2025 $-4.23 $246M
30 Jun 2025 Q2 2025 $-3.81 $242M
31 Mar 2025 Q1 2025 $-4.38 $231M
31 Dec 2024 FY 2024 $-101.92 $931M
30 Sep 2024 Q3 2024 $-24.25 $230M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CTEV institutional holders

SEC Form 13F

6 of the 45 institutional funds we track reported a CTEV position for the quarter ended 30 Jun 2026 — a combined $10.0M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Added +398.7% shares 174,011 $5.9M
Renaissance Technologies Held (±25%) −11.4% shares 46,015 $1.6M
Point72 Asset Management Trimmed −56.4% shares 39,000 $1.3M
Marshall Wace Trimmed −80.9% shares 13,533 $462K
Millennium Management Trimmed −48.7% shares 9,936 $339K
D. E. Shaw & Co. New position 9,580 $327K
Third Point Exited

Source: SEC EDGAR 13F filings

CTEV fails-to-deliver

SEC CNS data

On 25 Aug 2026, 1,844 shares of CTEV failed to deliver (about $67K) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
25 Aug 2026 1,844 $67K 0.011%
24 Aug 2026 100 $4K 0.001%
21 Aug 2026 13,878 $473K 0.082%
19 Aug 2026 830 $30K 0.005%
18 Aug 2026 14,655 $518K 0.086%

Source: SEC fails-to-deliver (CNS) data